Related Experiment Video
Updated: Jul 28, 2025

Oral Biofilm Sampling for Microbiome Analysis in Healthy Children
Published on: December 31, 2017
Oral-only antibiotics for bone and joint infections in children: study protocol for a nationwide randomised
Allan Bybeck Nielsen1, Luise Borch2,3, Mads Damkjaer4,5
1Department of Paediatrics and Adolescent Medicine, Copenhagen University Hospital, Kobenhavn, Denmark allan.bybeck.nielsen@regionh.dk.
Insights
This study investigates oral-only antibiotics for pediatric bone and joint infections, a novel approach not previously tested in randomized trials. Findings could reduce hospital stays and intravenous antibiotic use in children.
Area of Science:
- Pediatric Infectious Diseases
- Orthopedic Surgery
- Clinical Pharmacology
Background:
- Traditional treatment for pediatric bone and joint infections involves prolonged intravenous antibiotics followed by oral administration.
- Randomized trials evaluating oral-only antibiotic regimens for this patient population are lacking.
Purpose of the Study:
- To assess the non-inferiority of high-dose oral antibiotics compared to standard intravenous-to-oral antibiotic treatment in children with bone and joint infections.
- To evaluate the potential for reducing hospitalizations and intravenous antibiotic utilization.
Main Methods:
- A randomized controlled trial comparing high-dose oral antibiotics with standard intravenous-to-oral therapy in children aged 3 months to 18 years.
- Exclusion of children requiring acute surgery or with severe systemic illness (e.g., septic shock).
- Primary outcome: normal clinical assessment at 6 months post-treatment; secondary outcomes: treatment failure and recurrence.
Main Results:
- The study is designed to demonstrate that oral-only antibiotic therapy is non-inferior to the traditional approach.
- Anticipated minimal risk of treatment failure due to close monitoring and strict exclusion criteria.
Conclusions:
- This trial may establish oral-only antibiotic therapy as a viable and potentially less burdensome treatment option for pediatric bone and joint infections.
- Successful outcomes could lead to significant changes in clinical practice, reducing healthcare costs and improving patient experience.
Introduction:
Children with bone and joint infections are traditionally treated with intravenous antibiotics for 3-10 days, followed by oral antibiotics. Oral-only treatment has not been tested in randomised trials.
Methods And Analysis:
Children (3 months to 18 years) will be randomised 1:1 with the experimental group receiving high-dose oral antibiotics and the control group receiving intravenous antibiotics with a shift in both groups to standard oral antibiotics after clinical and paraclinical improvement. Children in need of acute surgery or systemic features requiring intravenous therapy, including septic shock, are excluded. The primary outcome is defined as a normal blinded standardised clinical assessment 6 months after end of treatment. Secondary outcomes are non-acute treatment failure and recurrent infection. Outcomes will be compared by a non-inferiority assumption with an inferiority margin of 5%.
Ethics And Dissemination:
The trial has the potential to reduce unnecessary hospitalisation and use of intravenous antibiotics in children with bone or joint infections. Due to the close follow-up, exclusion of severely ill children and predefined criteria for discontinuation of the allocated therapy, we expect the risk of treatment failure to be minimal.
Trial Registration Number:
NCT04563325.
Related Concept Videos
Tonsillitis II: Management
Antibiotic Selection
Essential Minerals for Bone Health
Calcium and Phosphorus
Calcium is a critical component of bones, especially in the form of calcium phosphate and calcium carbonate. Since the body cannot make calcium, it must be obtained from the diet. However, calcium cannot be absorbed from the small intestine without...
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Acute Pyelonephritis II: Diagnostic Studies and Management

